Wells Fargo cuts Integra LifeSciences price target to $15
AI Summary- Larry Biegelsen lowered Wells Fargo’s Integra LifeSciences price target to $15.
- 80% of the cut was attributed to flooding, Wells Fargo said.
- Integra preannounced preliminary Q3 results and lowered its outlook for the July flood impact.